CAV1 and benign prostatic hyperplasia: Notably, BPH tissue showed abundant stromal cav-1 immunostaining, whereas CaP showed an absence of stromal cav-1 directly correlating with CaP progression, as tumor metastases have been shown as negative for stromal cav-1 immunostaining [14].